AI assistant
MACOM Technology Solutions Holdings, Inc. — Director's Dealing 2017
Aug 17, 2017
30656_dirs_2017-08-17_ddb70981-068b-4a16-9c44-0b15a345896c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MACOM Technology Solutions Holdings, Inc. (MTSI)
CIK: 0001493594
Period of Report: 2017-08-07
Reporting Person: Rajgarhia Vivek (SVP & GM, Lightwave)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 51907 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $32.10 | 2022-11-13 | Common Stock (10000) | Direct | |
| Stock Option (Right to Buy) | $40.25 | 2023-11-09 | Common Stock (20000) | Direct |
Footnotes
F1: Includes (i) 5,000 restricted stock units ("RSUs") granted on March 14, 2017, which vest as follows: 1,250 RSUs vest on February 15, 2018, 1,250 RSUs vest on February 15, 2019, 1,250 RSUs vest on February 15, 2020 and 1,250 RSUs vest on February 15, 2021, provided that the Reporting Person remains in continuous service with the Issuer through each vesting date; (ii) 16,667 RSUs granted on July 20, 2016, which vest as follows: 8,333 RSUs vest on May 15, 2018 and 8,334 RSUs vest on May 15, 2019, provided that the Reporting Person remains in continuous service with the Issuer through each vesting date; (iii) 3,404 RSUs granted on March 17, 2016, which vest as follows: 1,134 RSUs vest on February 15, 2018, 1,134 RSUs vest on February 15, 2019 and 1,136 RSUs vest on February 15, 2020, provided that the Reporting Person remains in continuous service with the Issuer through each vesting date; (Footnote 1 continues in the Remarks section)
F2: 100% of the Stock Option shall become vested and exercisable in the event that the 30 trading day trailing average closing price per share of the Common Stock meets or exceeds $64.22 per share.
F3: 100% of the Stock Option shall become vested and exercisable in the event that the 30 trading day trailing average closing price per share of the Common Stock meets or exceeds $66.96 per share.